Shanghai Pharmaceuticals Holding Co., Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000012B3
HKD
10.97
-0.01 (-0.09%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

1.78 M

Shareholding (Dec 2022)

FII

0.01%

Held by 1 FIIs

DII

99.99%

Held by 0 DIIs

Promoter

0.00%

iScoreScore

Dashboard

1

High Debt company with Weak Long Term Fundamental Strength

  • Poor long term growth as Operating profit has grown by an annual rate -1.30% of over the last 5 years
  • The company is Net-Debt Free
2

Flat results in Dec 19

3

With ROE of 8.66%, it has a Very Expensive valuation with a 0.12 Price to Book Value

4

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

HKD 10,045 Million ()

stock-summary
P/E

1.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

4.74%

stock-summary
Debt Equity

0.17

stock-summary
Return on Equity

7.65%

stock-summary
Price to Book

0.11

Revenue and Profits:
Net Sales:
83,113 Million
(Quarterly Results - Jun 2026)
Net Profit:
2,868 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-7.35%
0%
-7.35%
6 Months
-0.9%
0%
-0.9%
1 Year
-9.79%
0%
-9.79%
2 Years
4.28%
0%
4.28%
3 Years
-13.21%
0%
-13.21%
4 Years
2.14%
0%
2.14%
5 Years
-30.13%
0%
-30.13%

Shanghai Pharmaceuticals Holding Co., Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
6.38%
EBIT Growth (5y)
-1.30%
EBIT to Interest (avg)
4.63
Debt to EBITDA (avg)
1.78
Net Debt to Equity (avg)
0.20
Sales to Capital Employed (avg)
2.17
Tax Ratio
26.52%
Dividend Payout Ratio
32.10%
Pledged Shares
0
Institutional Holding
0.01%
ROCE (avg)
9.27%
ROE (avg)
10.26%

Valuation key factors

Factor
Value
P/E Ratio
1
Industry P/E
Price to Book Value
0.12
EV to EBIT
4.12
EV to EBITDA
3.14
EV to Capital Employed
0.30
EV to Sales
0.10
PEG Ratio
0.06
Dividend Yield
NA
ROCE (Latest)
7.29%
ROE (Latest)
8.66%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2022stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.01%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is -2.14% vs 13.01% in Mar 2026",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 37.37% vs 92.72% in Mar 2026",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Mar'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "83,112.90",
          "val2": "84,927.40",
          "chgp": "-2.14%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3,818.70",
          "val2": "3,608.30",
          "chgp": "5.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "412.50",
          "val2": "392.30",
          "chgp": "5.15%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-68.40",
          "val2": "69.30",
          "chgp": "-198.70%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2,867.80",
          "val2": "2,087.70",
          "chgp": "37.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "35.50%",
          "val2": "32.50%",
          "chgp": "0.30%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 3.05% vs 3.87% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 18.84% vs 11.48% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "306,982.70",
          "val2": "297,900.20",
          "chgp": "3.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "12,136.80",
          "val2": "12,260.00",
          "chgp": "-1.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1,988.40",
          "val2": "2,150.30",
          "chgp": "-7.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-793.30",
          "val2": "-348.50",
          "chgp": "-127.63%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "7,563.20",
          "val2": "6,364.40",
          "chgp": "18.84%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "28.80%",
          "val2": "31.70%",
          "chgp": "-0.29%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQstock-summary

Jun'26
Mar'26
Change(%)
Net Sales
83,112.90
84,927.40
-2.14%
Operating Profit (PBDIT) excl Other Income
3,818.70
3,608.30
5.83%
Interest
412.50
392.30
5.15%
Exceptional Items
-68.40
69.30
-198.70%
Consolidate Net Profit
2,867.80
2,087.70
37.37%
Operating Profit Margin (Excl OI)
35.50%
32.50%
0.30%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2026 is -2.14% vs 13.01% in Mar 2026

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2026 is 37.37% vs 92.72% in Mar 2026

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
306,982.70
297,900.20
3.05%
Operating Profit (PBDIT) excl Other Income
12,136.80
12,260.00
-1.00%
Interest
1,988.40
2,150.30
-7.53%
Exceptional Items
-793.30
-348.50
-127.63%
Consolidate Net Profit
7,563.20
6,364.40
18.84%
Operating Profit Margin (Excl OI)
28.80%
31.70%
-0.29%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is 3.05% vs 3.87% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 18.84% vs 11.48% in Dec 2024

stock-summaryCompany CV
About Shanghai Pharmaceuticals Holding Co., Ltd. stock-summary
stock-summary
Shanghai Pharmaceuticals Holding Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Footer loading